MRCP UK EXAMINATIONS

RESPIRATORY

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
Based on GOLD 2019, COPD patients with FEV1 after administration of a 60% predicted bronchodilator, CAT (COPD Assessment Test) score of 8, history of exacerbations 2x in the last 1 year, including group patients:
A
GOLD 2, Group C
B
GOLD 2, Group D
C
GOLD 3, Group C
D
GOLD 3, Group D
Explanation: 

Detailed explanation-1: -GOLD 1-mild: FEV1 ≥80% predicted. GOLD 2-moderate: 50% ≤ FEV1 <80% predicted. GOLD 3-severe: 30% ≤ FEV1 <50% predicted. GOLD 4-very severe: FEV1 <30% predicted.

Detailed explanation-2: -Measurement of the bronchodilator response of forced expiratory volume in 1 second (FEV1) is an important method in clinical respiratory medicine. This measurement is used to predict the response to bronchodilator treatment and is part of the diagnosis of COPD and asthma.

Detailed explanation-3: -FEV1 helps measure the progression of lung conditions such as chronic obstructive pulmonary disease (COPD) or asthma. FEV stands for forced expiratory volume, which is the air you exhale in 1 second. A low FEV1 suggests a breathing obstruction. Having trouble breathing is a hallmark symptom of COPD.

Detailed explanation-4: -Non-Pharmacologic Therapy: The GOLD guidelines recommend smoking cessation, flu and pneumococcal vaccinations for patients with COPD in Groups A through D. Vaccinations are one way to reduce exacerbations, which are known to cause a more rapid decline in lung function, increased morbidity and mortality.

There is 1 question to complete.